title: The addition of topical doxepin to corticosteroid therapy: an improved treatment regimen for atopic dermatitis.
authors: Department of Dermatology, Georgetown University Medical Center, Washington, DC, USA.
authors: B J
authors: BJ
authors: Berberian
authors: D L
authors: DL
authors: Breneman
authors: L A
authors: LA
authors: Drake
authors: D
authors: D
authors: Gratton
authors: S S
authors: SS
authors: Raimir
authors: S
authors: S
authors: Phillips
authors: V I
authors: VI
authors: Sulica
authors: J E
authors: JE
authors: Bernstein
mesh_terms: D000279:Administration, Cutaneous; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000982:Antipruritics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004311:Double-Blind Method; D004316:Doxepin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D010146:Pain / Q000139:chemically induced; D012867:Skin / Q000187:drug effects / Q000473:pathology; D012894:Sleep Stages / Q000187:drug effects; D016896:Treatment Outcome; D014221:Triamcinolone / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000982:Antipruritics; D004316:Doxepin; D014221:Triamcinolone; D006854:Hydrocortisone